KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Depreciation and Depletion (2016 - 2026)

Bristol Myers Squibb has reported Depreciation and Depletion over the past 18 years, most recently at $139.0 million for Q1 2026.

  • Quarterly Depreciation and Depletion fell 15.76% to $139.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $595.0 million through Mar 2026, down 9.98% year-over-year, with the annual reading at $621.0 million for FY2025, 4.61% down from the prior year.
  • Depreciation and Depletion was $139.0 million for Q1 2026 at Bristol Myers Squibb, up from $132.0 million in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $169.0 million in Q4 2024 and troughed at $132.0 million in Q4 2025.
  • The 5-year median for Depreciation and Depletion is $153.0 million (2022), against an average of $153.5 million.
  • Year-over-year, Depreciation and Depletion increased 11.68% in 2022 and then fell 21.89% in 2025.
  • A 5-year view of Depreciation and Depletion shows it stood at $153.0 million in 2022, then increased by 6.54% to $163.0 million in 2023, then grew by 3.68% to $169.0 million in 2024, then fell by 21.89% to $132.0 million in 2025, then grew by 5.3% to $139.0 million in 2026.
  • Per Business Quant, the three most recent readings for BMY's Depreciation and Depletion are $139.0 million (Q1 2026), $132.0 million (Q4 2025), and $159.0 million (Q3 2025).